Men Call The Shots, But Avestria Invests in Women

Avestria Ventures has closed its Avestria Ventures Fund I to new investors. The venture capital fund is based in San Francisco's Bay Area. Avestria invests in women-led startups to help speed up transformation in the health sector.

The closure of Fund I is due to the sale of two of its portfolio companies this summer. Organon (NYSE: OGN), a women’s health company, bought its portfolio company Alydia Health for up to $240 million on 16 June. Following this, dietary supplement company Pharmavite bought another portfolio company Uqora for an undisclosed amount on 1 July.

“We believe that both of our focus areas – women’s health and female-led life science companies are ripe for innovation. And the two exits we’ve already had indicate that strategic investors are beginning to draw the...

Login In


Register now for free access

Notify of
Inline Feedbacks
View all comments